WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 …
Cytokinetics Inc Company Profile - GlobalData
WebCytokinetics is headquartered in South San Francisco, California, the US. Headquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, … WebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular … Pipeline - Cytokinetics Muscle Biology Therapies Home Cytokinetics, Inc. does not by its reference above or distribution imply its … Company - Cytokinetics Muscle Biology Therapies Home SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … The key to muscle function is contraction. The principal functionality of muscle is … Heart failure affects 64 million people worldwide, hospitalizes more Americans … holland america neptune lounge
Cytokinetics, Incorporated Company Profile South San Francisco…
WebFeb 17, 2024 · Cytokinetics has 5 employees across 2 locations and $94.59 m in annual revenue in FY 2024. See insights on Cytokinetics including office locations, … WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by … WebOct 8, 2024 · Cytokinetics, which hasn't commercialized a drug while burning through $945 million in its 23 years, had hoped to ask the Food and Drug Administration early next year to approve the drug. The... human events periodical